Intratumoral heterogeneity of Ki67 expression in early breast cancers exceeds variability between individual tumours
Histopathology2016Vol. 69(5), pp. 849–861
Citations Over TimeTop 19% of 2016 papers
Abstract
Intratumoral heterogeneity in Ki67-LI is a ubiquitous phenomenon across various pathological subgroups of breast cancer that may impact assessment of Ki67 levels for clinical decision-making, and sheds new light on recommended cut-offs.
Related Papers
- → Novel combination of serum microRNA for detecting breast cancer in the early stage(2016)358 cited
- → High Estrogen Receptor β Expression Is Prognostic among Adjuvant Chemotherapy–Treated Patients—Results from a Population-Based Breast Cancer Cohort(2016)27 cited
- Expression and prognostic value of estrogen receptor beta in breast cancer patients.(2014)
- Exploration of pathological characterististics on breast cancer in aged women over 70 years(2008)